Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
about
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyBiomimetic and synthetic interfaces to tune immune responsesLinking form to function: Biophysical aspects of artificial antigen presenting cell designThe era of bioengineering: how will this affect the next generation of cancer immunotherapy?Biomaterials for nanoparticle vaccine delivery systems.Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters).Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle designKiller artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells.Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradationBiomaterials and emerging anticancer therapeutics: engineering the microenvironment.Assembly and Immunological Processing of Polyelectrolyte Multilayers Composed of Antigens and Adjuvants.Engaging adaptive immunity with biomaterialsHarnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.Biomimetic particles as therapeutics.Drug delivery by supramolecular design.Engineered Materials for Cancer Immunotherapy.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.Emerging nanotechnologies for cancer immunotherapyDesign Advances in Particulate Systems for Biomedical Applications.Mimicking biological functionality with polymers for biomedical applications.Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.T cell immunoengineering with advanced biomaterials.Biomaterial strategies for generating therapeutic immune responses.Janus particles as artificial antigen-presenting cells for T cell activation.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Surface engineering for lymphocyte programming.An in silico analysis of nanoparticle/cell diffusive transfer: application to nano-artificial antigen-presenting cell:T-cell interaction.An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles.Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activationAdvanced manufacturing of microdisk vaccines for uniform control of material properties and immune cell function.Improving Vaccine and Immunotherapy Design Using Biomaterials.Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity.Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells.Janus Nanoparticles for T Cell Activation: Clustering Ligands to Enhance Stimulation.Artificial Antigen-Presenting Cells for Immunotherapies.Detection of CD28/CD86 co-stimulatory molecules and surface properties of T and dendritic cells: An AFM study.
P2860
Q26782566-92D507BD-0B26-4731-8B05-14AF7892C942Q26801229-4D5ED68A-8373-4639-963F-86700525C638Q27002652-2EE95546-87C3-4F1C-8DD5-7FA7810B0482Q33815087-653155E8-C7D4-4474-B7AA-53C1700D9727Q34345012-6EAAB44A-E8F5-48CB-A74F-678DB5F1ABBBQ34428078-30DF8F83-9371-45C6-98AE-C0ABEA7CBB56Q34964232-D10A14CD-5F0B-4193-9F14-787791F0B73EQ36225449-5F300A5B-85DB-4AB7-B22D-872CC9A29245Q36279715-4BD481BC-7AF1-4D1C-A148-CA30E9F42E28Q36454872-0FAEE789-1065-4D48-8F51-EEBD625264D5Q36581724-DC8B53E0-7FBE-48A0-8C69-FDA22045AB6AQ36684345-A08B2722-CB14-452C-A839-FBFEF4D3318FQ37137425-1E4B21E7-3096-4D30-B434-BE68BB88315FQ37691850-81173D63-74DB-4DF5-BDA4-3E4C047378EBQ38297557-41895380-0183-460C-BBF7-4B40767F85C6Q38567436-2B4AF7A0-16FA-409C-9935-0A5ED4CC11CBQ38638945-25773EFE-1042-4AB9-8C8F-180DA227B3E4Q38660577-F57328DA-0BA5-4710-B218-BB4A1646E38DQ38677432-D7119F4C-43EF-40D6-8E61-5578974C0C5AQ38684217-32E7B322-897A-460E-9E96-5DDE5C1FF22FQ38837036-BF98AA33-4488-4F6B-BB2C-8B0DC95DE802Q38873026-D6C45620-E5DC-42B6-9A70-DCE8D499943EQ39038679-358AF703-91EC-472B-9E64-DD21C352D1E2Q39111861-DA977894-7E14-49F6-A215-D7458B4114B8Q39157864-38B2ECAE-F39A-42E3-A40C-7861DE7E6139Q39271088-55458D99-D403-4F5B-AA08-D9E85990AD3AQ39815875-CB49DCDF-7CA7-4456-A535-F860EA8D9BD7Q40044791-B872397A-740A-418D-84DE-03334CD0B222Q40214162-B21F5C17-5F55-4052-9020-36A560AF7BEBQ41477320-0AEE1929-F7A4-46E8-9F68-330D7C262B59Q41495734-4D5711F8-CA16-41FE-8F71-2A22D39669FFQ41495742-68D7907F-20DE-4B3D-B427-E9E94F2F4F80Q47312662-8912A1C6-B3AE-47DE-8F3D-40B3AC7E63A1Q47676665-A630621B-5E2E-4BAF-99AC-52DD195741B0Q47730058-D57322E3-7FEB-4F72-968E-35A60CEA3B1EQ48016268-C5862CCB-DE04-4E08-8F9B-7762D93C60B7Q48243270-8C6A4D98-E7CC-4AF8-8691-417096BF34E7Q48644573-B38EC65B-BA43-492B-8A1C-D0698714551DQ51021209-92534085-63DD-4FCF-8544-68837A1E1446Q51670548-8870E976-5D1E-4B33-ABB0-7FA3C2511E9B
P2860
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Particle shape dependence of C ...... icial antigen presenting cells
@en
Particle shape dependence of C ...... cial antigen presenting cells.
@nl
type
label
Particle shape dependence of C ...... icial antigen presenting cells
@en
Particle shape dependence of C ...... cial antigen presenting cells.
@nl
prefLabel
Particle shape dependence of C ...... icial antigen presenting cells
@en
Particle shape dependence of C ...... cial antigen presenting cells.
@nl
P2860
P1433
P1476
Particle shape dependence of C ...... icial antigen presenting cells
@en
P2093
Jonathan P Schneck
Jordan J Green
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.09.050
P577
2013-10-05T00:00:00Z